Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with U.S. FDA PDUFA goal date of August 15, 2025 ...

H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...

Peripheral nerves are nerves located outside the brain and spinal cord. They relay information between the central nervous system (CNS) and all other parts of the body. The brain and spinal cord ...

Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer ---- Key additions expected to support company’s ...